Dyspepsia in primary care - To prescribe or to investigate?

British Journal of General Practice

Volumn 51, Issue 469, 2001, Pages 612-614

  Ghosh, S ^a   Kinnear, M ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; CISAPRIDE; DOMPERIDONE; HISTAMINE H2 RECEPTOR ANTAGONIST; METOCLOPRAMIDE; OMEPRAZOLE; PROKINETIC AGENT; PROTON PUMP INHIBITOR; STOMACH SECRETION INHIBITOR;

ANTIBIOTIC RESISTANCE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DYSPEPSIA; EDITORIAL; ENDOSCOPY; ERADICATION THERAPY; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMAN; LIFESTYLE; META ANALYSIS; NONHUMAN; PRESCRIPTION; PRIMARY HEALTH CARE; SYMPTOMATOLOGY; ULCER;

DYSPEPSIA; ENDOSCOPY, GASTROINTESTINAL; FAMILY PRACTICE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; REFERRAL AND CONSULTATION;

EID: 0034902046     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (24)

1. 2-blocker therapy or prompt endoscopy in management of dyspepsia
2. The Omega project - A comparison of two diagnostic strategies for risk- and cost-oriented management of dyspepsia
3. Prospective screening of dyspeptic patients by Helicobacter pylori serology
4. A helicobacter test and treat strategy: Costs and outcomes in a randomised controlled trial in primary care
5. A prospective randomised trial of a 'test and treat' policy versus endoscopy based management in young Helicobacter pylori-positive patients with ulcer-like dyspepsia, referred to a hospital clinic
6. A randomised controlled trial of four management strategies for dyspepsia: Relationships between symptom subgroups and strategy outcome
7. Dutch College of general practitioners guidelines on dyspepsia
8. Lack of effect of treating Helicobacter pylori infection in patients with non-ulcer dyspepsia. Omeprazole plus clarithromycin and amoxycillin effect one year after treatment (OCAY) study group
9. Eradication of Helicobacter pylori in functional dyspepsia: Randomised double-blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) study group
10. Absence of benefit of eradicating Helicobacter pylori in patients with non-ulcer dyspepsia
11. Treatment of Helicobacter pylori (HP) does not improve symptoms of functional dyspepsia (FD)
12. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with non-ulcer dyspepsia
13. Is Helicobacter pylori associated with non-ulcer dyspepsia and will eradication improve symptoms? A meta-analysis
14. Therapy for Helicobacter pylori in patients with non-ulcer dyspepsia
15. Initial management strategies for dyspepsia
16. Pharmacological interventions for non-ulcer dyspepsia
17. Management of dyspepsia: Report of a working party
18. Functional gastroduodenal disorders
19. Factors associated with consulting medical or non-medical practitioners for dyspepsia: An Australian population-based study
20. The prevalence of dyspepsia and use of anti-secretory medication in North Glasgow: Role of Helicobacter pylori vs. lifestyle factors
21. Dyspepsia in England and Scotland
22. The initial management of uninvestigated dyspepsia in younger patients - the value of symptom-guided strategies should be reconsidered
23. Randomised controlled trial of Helicobacter pylori testing and endoscopy for dyspepsia in primary care
24. Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: A randomised controlled trial in primary care